Plasmapheresis has been confirmed a second time as a selective treatment for patterns I and II. This has been consistently reported since 2005.
Tissue Markers for Acute Multiple Sclerosis Treatment Response—A Step Toward Personalized Medicine
JAMA neurology, February 5, 2018
https://www.ncbi.nlm.nih.gov/pubmed/16099294 and
https://jamanetwork.com/journals/jamane ... irect=true
Extract:
Many of the same investigators involved in the original lesion pattern study applied their lesion classification schema to short-term response to treatment.
This retrospective study evaluated short-term clinical responses to apheresis (plasmapheresis), stratified by 3 of the 4 lesion patterns. Among those with T-cell mediated autoimmune pathology, 31% to 55% demonstrated functional response to apheresis.
Researchers suggested that T-cell mediated autoimmune pathology with antibody and complement activation (pattern 2) responded the best. None of the patients with oligodendrocytopathy (pattern 3) demonstrated improvement.
See also:
http://www.thisisms.com/forum/drug-pipe ... c4567.html
and
https://jamanetwork.com/journals/jamane ... irect=true (Feb. 2018)
and
https://jamanetwork.com/journals/jamane ... irect=true (Feb. 2018)
Patterns: Plasmapheresis confirmed as selective treatment.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 793 Views
-
Last post by frodo
-
- 0 Replies
- 1200 Views
-
Last post by frodo
-
- 0 Replies
- 971 Views
-
Last post by frodo
-
- 5 Replies
- 2244 Views
-
Last post by Jaded
-
- 0 Replies
- 8808 Views
-
Last post by NHE
-
- 0 Replies
- 3960 Views
-
Last post by NHE
-
- 0 Replies
- 1862 Views
-
Last post by frodo
-
- 0 Replies
- 2121 Views
-
Last post by Cece
-
- 0 Replies
- 2333 Views
-
Last post by NHE